Search for: "Mylan Pharmaceuticals"
Results 121 - 140
of 738
Sort by Relevance
|
Sort by Date
5 Apr 2020, 9:57 pm
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan Pharmaceuticals ULC v Eli Lilly… [read post]
9 Jan 2020, 8:25 pm
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
13 Nov 2019, 9:15 am
” Similarly, the Board held in Mylan Pharmaceuticals Inc. v. [read post]
22 Oct 2019, 9:15 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
27 Sep 2019, 7:20 am
The Securities and Exchange Commission today announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and disclosure failures relating to a Department of Justice (DOJ) probe into whether Mylan overcharged Medicaid by…Read the Full Press ReleaseWant to talk to a securities lawyer? [read post]
19 Sep 2019, 9:43 pm
Mylan Pharmaceuticals Inc.; Regents of the University of Minnesota v. [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
15 Aug 2019, 9:05 pm
District Court for the District of Connecticut against Heritage, Mylan, Teva, and other pharmaceutical manufacturers. [read post]
Inversion Reversion: Deals to Move Corporate HQs Outside U.S. Lose Favor Due to Smaller Tax Benefits
3 Aug 2019, 6:00 am
When Mylan moved its corporate address to the Netherlands in 2015, the pharmaceutical company joined a wave of corporate inversion deals aided by tax advantages of... [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
18 Jun 2019, 11:31 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d... [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
15 May 2019, 5:27 am
Besides Teva, also Sandoz, Novartis, Mylan and Pfizer are mentioned, among others. [read post]
14 May 2019, 11:24 am
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
13 May 2019, 1:45 pm
(credit: Getty | Fred Dufour) Twenty leading drug companies—including Teva Pharmaceuticals, Pfizer, Novartis, and Mylan—were in cahoots for years to fix and dramatically inflate the prices of more than 100 generic drugs, in some cases to raising prices "well over 1,000 percent," according to a lawsuit filed late last week by 44 states. [read post]
